Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention of Nosocomial Pneumonia

Next Previous
X
Search
Trial Profile

A Phase 3, Randomized, Double-blind, Placebo-controlled, Single-dose Study to Evaluate the Efficacy and Safety of Suvratoxumab in Mechanically Ventilated Adults and Adolescents for the Prevention of Nosocomial Pneumonia

Status: Suspended
Phase of Trial: Phase III

Latest Information Update: 29 May 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Suvratoxumab (Primary)
  • Indications Nosocomial pneumonia
  • Focus Registrational; Therapeutic Use
  • Acronyms SAATELLITE-2
  • Sponsors Aridis Pharmaceuticals

    • Most Recent Events

    • 08 Jun 2023 According to an Aridis Pharmaceuticals media release, the company placed this trial on while the it discusses potential resolutions with AstraZeneca on the commercial license.
    • 31 Mar 2023 Status changed from recruiting to suspended, according to an Aridis Pharmaceuticals media release.
    • 31 Mar 2023 According to an Aridis Pharmaceuticals media release, company has placed this study on hold and The Companys operating expenses have been significantly lowered with the AR-320-003 trial on hold,

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top